An Entity of Type: S.A. (corporation), from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.

Property Value
dbo:abstract
  • DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration. (en)
  • DBV Technologies est une entreprise française, créée en 2002 qui développe des solutions de diagnostic et de traitement des allergies alimentaires, arachide et lait de vache. Elle est cotée à la bourse de Paris. (fr)
dbo:foundingYear
  • 2002-01-01 (xsd:gYear)
dbo:industry
dbo:keyPerson
dbo:thumbnail
dbo:type
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 38460994 (xsd:integer)
dbo:wikiPageLength
  • 11746 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1123864815 (xsd:integer)
dbo:wikiPageWikiLink
dbp:foundation
  • Bagneux, France (en)
dbp:founder
  • (en)
  • Bertrand Dupont (en)
  • Christophe Dupont (en)
dbp:industry
dbp:keyPeople
  • (en)
  • Kevin Trapp (en)
  • Daniel Tasse (en)
  • Ramzi Benamar (en)
dbp:locationCity
dbp:locationCountry
dbp:logo
  • DBV Technologies logo.svg (en)
dbp:logoSize
  • 100 (xsd:integer)
dbp:name
  • DBV Technologies SA (en)
dbp:products
  • Allergy treatments, Allergy diagnosis (en)
dbp:tradeName
  • DBV Technologies (en)
dbp:tradedAs
dbp:type
dbp:wikiPageUsesTemplate
dcterms:subject
rdf:type
rdfs:comment
  • DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration. (en)
  • DBV Technologies est une entreprise française, créée en 2002 qui développe des solutions de diagnostic et de traitement des allergies alimentaires, arachide et lait de vache. Elle est cotée à la bourse de Paris. (fr)
rdfs:label
  • DBV Technologies (en)
  • DBV Technologies (fr)
owl:sameAs
skos:closeMatch
prov:wasDerivedFrom
foaf:depiction
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • DBV Technologies SA (en)
is dbo:wikiPageDisambiguates of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License